www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Combined-Shareholders-Meeting-of-IPSEN-S-A-Held-on-1-June-2012-1894927 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} --> </style> <p class="bwalignl"> Regulatory News: <!-- sh_cad_1 --> The Combined Shareholders’ Meeting of Ipsen S.A. (Paris:IPN) (Euronext: ...http://www.finanzen.net/nachricht/Combined-Shareholders-Meeting-of-IPSEN-S-A-Held-on-1-June-2012-1894927http://www.finanzen.net/nachricht/600-Patients-Recruited-in-Active-Biotech-s-and-Ipsen-s-tasquinimod-Clinical-Phase-III-Study-1876728 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwlistitemmargb {margin-bottom: 10.0px} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: Active Biotech (NASDAQ OMX NORDIC: ...http://www.finanzen.net/nachricht/600-Patients-Recruited-in-Active-Biotech-s-and-Ipsen-s-tasquinimod-Clinical-Phase-III-Study-1876728http://www.finanzen.net/nachricht/Active-Biotech-and-Ipsen-to-Present-Tasquinimod-Phase-II-Overall-Survival-Data-at-the-2012-ASCO-Annual-Meeting-1874631 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Paris:IPN) (Euronext: ...http://www.finanzen.net/nachricht/Active-Biotech-and-Ipsen-to-Present-Tasquinimod-Phase-II-Overall-Survival-Data-at-the-2012-ASCO-Annual-Meeting-1874631http://www.finanzen.net/nachricht/Ipsen-Monthly-Information-Regarding-the-Total-Number-of-Voting-Rights-and-Total-Number-of-Shares-of-the-Company-1852974 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwnowrap {white-space: nowrap} .bwpadl0 {padding-left: 0.0px} .bwpadr0 {padding-right: 0.0px} .bwsinglebottom ...http://www.finanzen.net/nachricht/Ipsen-Monthly-Information-Regarding-the-Total-Number-of-Voting-Rights-and-Total-Number-of-Shares-of-the-Company-1852974http://www.finanzen.net/nachricht/Ipsen-Combined-Shareholders-Meeting-of-June-1-2012-1841974 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwlistitemmargb {margin-bottom: 10.0px} --> </style> <!-- sh_cad_1 --> Regulatory News: Ipsen SA (Paris:IPN): The Shareholders of the Company ...http://www.finanzen.net/nachricht/Ipsen-Combined-Shareholders-Meeting-of-June-1-2012-1841974http://www.finanzen.net/nachricht/Ipsen-s-First-Quarter-2012-Sales-1837836 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmargb {margin-bottom: 10.0px} .bwmarginl1 {margin-left: 30.0px} .bwmarginl2 ...http://www.finanzen.net/nachricht/Ipsen-s-First-Quarter-2012-Sales-1837836http://www.finanzen.net/nachricht/Ipsen-Description-of-the-share-repurchase-program-proposed-by-the-Board-of-directors-to-the-approval-of-the-Combined-Shareholders-Meeting-to-be-held-on-June-1-2012-1822742 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwnowrap {white-space: nowrap} .bwpadl0 {padding-left: 0.0px} .bwpadr0 {padding-right: 0.0px} .bwtablemarginb {margin-bottom: 10.0px} .bwvertalignt ...http://www.finanzen.net/nachricht/Ipsen-Description-of-the-share-repurchase-program-proposed-by-the-Board-of-directors-to-the-approval-of-the-Combined-Shareholders-Meeting-to-be-held-on-June-1-2012-1822742http://www.finanzen.net/nachricht/Ipsen-Pursues-Its-Development-in-the-United-States-with-the-Opening-of-Its-New-Commercial-Headquarters-in-New-Jersey-NJ-1817828 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwlistitemmargb {margin-bottom: 10.0px} --> </style> <!-- sh_cad_1 --> Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced the ...http://www.finanzen.net/nachricht/Ipsen-Pursues-Its-Development-in-the-United-States-with-the-Opening-of-Its-New-Commercial-Headquarters-in-New-Jersey-NJ-1817828http://www.finanzen.net/nachricht/Ipsen-s-Partner-Inspiration-Biopharmaceuticals-Announces-US-Filing-of-Biologics-License-Application-BLA-for-IB1001-a-Recombinant-Factor-IX-Product-for-the-Treatment-of-Hemophilia-B-1798606 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> Ipsen (Paris:IPN) (Euronext: IPN, ADR: IPSEY) today announced that its partner, Inspiration Biopharmaceuticals, ...http://www.finanzen.net/nachricht/Ipsen-s-Partner-Inspiration-Biopharmaceuticals-Announces-US-Filing-of-Biologics-License-Application-BLA-for-IB1001-a-Recombinant-Factor-IX-Product-for-the-Treatment-of-Hemophilia-B-1798606http://www.finanzen.net/nachricht/IPSEN-Monthly-Information-Regarding-the-Total-Number-of-Voting-Rights-and-Total-Number-of-Shares-of-the-Company-1780927 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwnowrap {white-space: nowrap} .bwpadl0 {padding-left: 0.0px} .bwpadr0 {padding-right: 0.0px} .bwsinglebottom ...http://www.finanzen.net/nachricht/IPSEN-Monthly-Information-Regarding-the-Total-Number-of-Voting-Rights-and-Total-Number-of-Shares-of-the-Company-1780927